The Systemic Lupus International Collaborating Clinics Group--origins and outcomes

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Lupus·2013

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Lupus·2013

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Lupus·2013

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Lupus·2013

Rheumatological manifestations occurring in patients with diabetes mellitus.

Scandinavian journal of rheumatology·2012

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

Psychology & health·2012

A structured primary care-led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice.

Lupus·2026

Uncertainty in illness and psychological adjustment in patients with systemic lupus erythematosus.

Lupus·2026

Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months.

Lupus·2026

Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: A meta-analysis.

Lupus·2026

IFI44L promoter hypomethylation as an epigenetic biomarker of systemic lupus erythematosus: A systematic review and meta-analysis.

Lupus·2026

Interstitial palladin is associated with tubulointerstitial chronicity and adverse outcomes in patients with lupus nephritis.

Lupus·2026

Real-World Outcomes of Baricitinib in Patients with Rheumatoid Arthritis: A Two-Year Observational Study of Overall and Difficult-to-Treat Patients in Japan.

Modern rheumatology·2026

Differentiating pulmonary sarcoidosis from pulmonary tuberculosis in clinical practice: Insights from routine blood tests.

Irish journal of medical science·2026

Reduction of CXCR3+CCR6+ CD4+ T Cells and IL-17+ RORγt+ CD4+ T Cells During Secukinumab Treatment Identifies Patients With Axial Spondyloarthritis Responsive to Subsequent Biologic Therapy.

ACR open rheumatology·2026

Longitudinal changes in renal function in rheumatoid arthritis patients treated with biologic agents: a retrospective cohort study.

Clinical rheumatology·2026

Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2026

Distinct spondyloarthritis phenotypes and disease burden in patients with concomitant hidradenitis suppurativa.

Seminars in arthritis and rheumatism·2026

Related Experiment Videos

The Systemic Lupus International Collaborating Clinics Group--origins and outcomes

Related Concept Videos

The cost of care of systemic lupus erythematosus (SLE) in the UK: annual direct costs for adult SLE patients with active autoantibody-positive disease.

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus--report of 17 cases and review of the literature.

Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry's disease.

Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.

Rheumatological manifestations occurring in patients with diabetes mellitus.

What constitutes uncertainty in systemic lupus erythematosus and rheumatoid arthritis?

A structured primary care-led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice.

Uncertainty in illness and psychological adjustment in patients with systemic lupus erythematosus.

Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months.

Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: A meta-analysis.

IFI44L promoter hypomethylation as an epigenetic biomarker of systemic lupus erythematosus: A systematic review and meta-analysis.

Interstitial palladin is associated with tubulointerstitial chronicity and adverse outcomes in patients with lupus nephritis.

Real-World Outcomes of Baricitinib in Patients with Rheumatoid Arthritis: A Two-Year Observational Study of Overall and Difficult-to-Treat Patients in Japan.

Differentiating pulmonary sarcoidosis from pulmonary tuberculosis in clinical practice: Insights from routine blood tests.

Reduction of CXCR3+CCR6+ CD4+ T Cells and IL-17+ RORγt+ CD4+ T Cells During Secukinumab Treatment Identifies Patients With Axial Spondyloarthritis Responsive to Subsequent Biologic Therapy.

Longitudinal changes in renal function in rheumatoid arthritis patients treated with biologic agents: a retrospective cohort study.

Comparison of the Risk of Acute Anterior Uveitis Flare Between Adalimumab and Subcutaneous Infliximab in Patients with Radiographic Axial Spondyloarthritis and Prior Acute Anterior Uveitis: A Randomized Controlled Trial.

Distinct spondyloarthritis phenotypes and disease burden in patients with concomitant hidradenitis suppurativa.

Related Experiment Videos

The Systemic Lupus International Collaborating Clinics Group--origins and outcomes

Related Concept Videos

Related Articles